Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.
about
Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell CarcinomaAngiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.
P2860
Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@ast
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@en
type
label
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@ast
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@en
prefLabel
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@ast
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@en
P2093
P2860
P50
P356
P1476
Sunitinib combined with angiot ...... model of renal cell carcinoma.
@en
P2093
Audrey Lavenu
Cécile Vigneau
Emmanuel Oger
Florence Jouan
Grégory Verhoest
Karim Bensalah
Nicolas Collet
Thibault Dolley-Hitze
P2860
P304
P356
10.1155/2014/901371
P407
P577
2014-05-22T00:00:00Z